Cargando…

Clinical use of Dieletrophoresis separation for live Adipose derived stem cells

BACKGROUND: Microelectrode dieletrophoresis capture of live cells has been explored in animal and cellular models ex-vivo. Currently, there is no clinical data available regarding the safety and efficacy of dielectrophoresis (DEP) buffers and microcurrent manipulation in humans, despite copious pre-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Allan Y, Morrow, David M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477126/
https://www.ncbi.nlm.nih.gov/pubmed/22594610
http://dx.doi.org/10.1186/1479-5876-10-99
_version_ 1782247196727443456
author Wu, Allan Y
Morrow, David M
author_facet Wu, Allan Y
Morrow, David M
author_sort Wu, Allan Y
collection PubMed
description BACKGROUND: Microelectrode dieletrophoresis capture of live cells has been explored in animal and cellular models ex-vivo. Currently, there is no clinical data available regarding the safety and efficacy of dielectrophoresis (DEP) buffers and microcurrent manipulation in humans, despite copious pre-clinical studies suggesting its safety. The purpose of this study was to determine if DEP isolation of SVF using minimal manipulation methods is safe and efficacious for use in humans using the hand lipotransfer model. METHODS: Autologous stromal vascular fraction cells (SVF) were obtained from lipoaspirate by collagenase digestion and centrifugation. The final mixture of live and dead cells was further processed using a custom DEP microelectrode array and microcurrent generator to isolate only live nucleated cells. Lipotransfer was completed using fat graft enhanced with either standard processed SVF (control) versus DEP filtered SVF (experimental). Spectral photography, ultrasound and biometric measurements were obtained at post operatively days 1, 4, 7, 14, 30, 60 and 90. RESULTS: The DEP filter was capable of increasing SVF viability counts from 74.3 ± 2.0% to 94.7 ± 2.1%. Surrogate markers of inflammation (temperature, soft tissue swelling, pain and diminished range of motion) were more profound on the control hand. Clinical improvement in hand appearance was appreciated in both hands, though the control hand exclusively sustained late phase erosive skin breaks on post operative day 7. No skin breaks were appreciated on the DEP-SVF treated hand. Early fat engraftment failure was noted on the control hand thenar web space at 3 months post surgery. DISCUSSION: No immediate hypersensitivity or adverse reaction was appreciated with the DEP-SVF treated hand. In fact, the control hand experienced skin disruption and mild superficial cellulitis, whereas the experimental hand did not experience this complication, suggesting a possible “protective” effect with DEP filtered SVF. Late ultrasound survey revealed larger and more frequent formation of oil cysts in the control hand, also suggesting greater risk of engraftment failure with standard lipotransfer. CONCLUSION: Clinical DEP appears safe and efficacious for human use. The DEP microelectrode array was found to be versatile and robust in efficiently isolating live SVF cells from dead cells and cellular debris in a time sensitive clinical setting.
format Online
Article
Text
id pubmed-3477126
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34771262013-09-25 Clinical use of Dieletrophoresis separation for live Adipose derived stem cells Wu, Allan Y Morrow, David M J Transl Med Research BACKGROUND: Microelectrode dieletrophoresis capture of live cells has been explored in animal and cellular models ex-vivo. Currently, there is no clinical data available regarding the safety and efficacy of dielectrophoresis (DEP) buffers and microcurrent manipulation in humans, despite copious pre-clinical studies suggesting its safety. The purpose of this study was to determine if DEP isolation of SVF using minimal manipulation methods is safe and efficacious for use in humans using the hand lipotransfer model. METHODS: Autologous stromal vascular fraction cells (SVF) were obtained from lipoaspirate by collagenase digestion and centrifugation. The final mixture of live and dead cells was further processed using a custom DEP microelectrode array and microcurrent generator to isolate only live nucleated cells. Lipotransfer was completed using fat graft enhanced with either standard processed SVF (control) versus DEP filtered SVF (experimental). Spectral photography, ultrasound and biometric measurements were obtained at post operatively days 1, 4, 7, 14, 30, 60 and 90. RESULTS: The DEP filter was capable of increasing SVF viability counts from 74.3 ± 2.0% to 94.7 ± 2.1%. Surrogate markers of inflammation (temperature, soft tissue swelling, pain and diminished range of motion) were more profound on the control hand. Clinical improvement in hand appearance was appreciated in both hands, though the control hand exclusively sustained late phase erosive skin breaks on post operative day 7. No skin breaks were appreciated on the DEP-SVF treated hand. Early fat engraftment failure was noted on the control hand thenar web space at 3 months post surgery. DISCUSSION: No immediate hypersensitivity or adverse reaction was appreciated with the DEP-SVF treated hand. In fact, the control hand experienced skin disruption and mild superficial cellulitis, whereas the experimental hand did not experience this complication, suggesting a possible “protective” effect with DEP filtered SVF. Late ultrasound survey revealed larger and more frequent formation of oil cysts in the control hand, also suggesting greater risk of engraftment failure with standard lipotransfer. CONCLUSION: Clinical DEP appears safe and efficacious for human use. The DEP microelectrode array was found to be versatile and robust in efficiently isolating live SVF cells from dead cells and cellular debris in a time sensitive clinical setting. BioMed Central 2012-05-17 /pmc/articles/PMC3477126/ /pubmed/22594610 http://dx.doi.org/10.1186/1479-5876-10-99 Text en Copyright © 2012 Wu and Morrow; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Wu, Allan Y
Morrow, David M
Clinical use of Dieletrophoresis separation for live Adipose derived stem cells
title Clinical use of Dieletrophoresis separation for live Adipose derived stem cells
title_full Clinical use of Dieletrophoresis separation for live Adipose derived stem cells
title_fullStr Clinical use of Dieletrophoresis separation for live Adipose derived stem cells
title_full_unstemmed Clinical use of Dieletrophoresis separation for live Adipose derived stem cells
title_short Clinical use of Dieletrophoresis separation for live Adipose derived stem cells
title_sort clinical use of dieletrophoresis separation for live adipose derived stem cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477126/
https://www.ncbi.nlm.nih.gov/pubmed/22594610
http://dx.doi.org/10.1186/1479-5876-10-99
work_keys_str_mv AT wuallany clinicaluseofdieletrophoresisseparationforliveadiposederivedstemcells
AT morrowdavidm clinicaluseofdieletrophoresisseparationforliveadiposederivedstemcells